St. Jude Reference #SJ-06-0013
Description
An animal vaccine composition and method effective in preventing or ameliorating avian influenza virus (“bird flu”) infection is provided. The vaccine contains at least two inactivated viral strains with a combined hemagglutinin total of at least 200 HA/dose.
Keywords
bird flu, vaccine, H5N1, H5N3
Granted patents or published applications
Granted patents in the US (9,072,701), Hong Kong, Africa (ARIPO) and China; and patents pending in Indonesia, Vietnam, Egypt, and Africa (OAPI).
Related scientific references
Webster, R.G. et al., “The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens”, Virology 351(2): 303-311 (2006).
Licensing opportunities
We are currently seeking nonexclusive licensing opportunities in all fields for the development of this technology. These patent rights are co-owned with Fort Dodge Animal Health, a division of Wyeth. Contact: chad.riggs@stjude.org
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.